Skip to main content
. 2010 Oct 5;2010:731426. doi: 10.1155/2010/731426

Figure 1.

Figure 1

The full analysis set, which consisted of all patients who received at least one dose of study drug, included 318 patients in the Tac/SRL group and 316 patients in the Tac/MMF group. More patients in the Tac/SRL group withdrew from the study prematurely, the majority because of an adverse event.